Implanet S.A. (EPA:ALIMP)

Market Cap	21.12M
Revenue (ttm)	9.41M
Net Income (ttm)	-4.37M
Shares Out	124.97M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,562,636
Average Volume	306,688
Open	0.1060
Previous Close	0.1095
Day's Range	0.1060 - 0.1860
52-Week Range	0.0800 - 0.1860
Beta	0.99
RSI	79.93
Earnings Date	Sep 16, 2025

About Implanet

Implanet S.A., a medical technology company, manufactures and sells implants and instrument for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. It also provides ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. Implanet S.A.was founded in 2006 and is based in Martill...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 46
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALIMP

Financial Performance

In 2024, Implanet's revenue was 9.41 million, an increase of 26.31% compared to the previous year's 7.45 million. Losses were -4.37 million, -34.60% less than in 2023.